article Open AccessTop 10% cited

Circulating mutant DNA to assess tumor dynamics

Nature Medicine · 2008 · Vol. 14(9) · pp. 985–990

Frank Diehl✉(Cancer Genetics (United States))Kerstin Schmidt(Howard Hughes Medical Institute)Michael A. Choti(Johns Hopkins University)Katharine Romans(Sidney Kimmel Cancer Center)Steven N. Goodman(Johns Hopkins University)Meng Li(Johns Hopkins University)Katherine A. Thornton(Howard Hughes Medical Institute)Nishant Agrawal(Howard Hughes Medical Institute)Lori J. Sokoll(Johns Hopkins University)Steve Szabo(Sidney Kimmel Cancer Center)Kenneth W. Kinzler(Howard Hughes Medical Institute)Bert Vogelstein(Cancer Genetics (United States))Luis A. Díaz(Howard Hughes Medical Institute)

View via DOI Publisher page

Cancer Genomics and Diagnostics Genetic factors in colorectal cancer Lung Cancer Treatments and MutationsCirculating tumor DNAColorectal cancerSomatic cellCancerDNAMutantBiologyNucleic acidMutationCancer research

MeSH terms

DNA Mutational AnalysisDNA, NeoplasmFlow CytometryFluorescent DyesHumansMagneticsRecurrenceColorectal NeoplasmsBiomarkersNucleic Acid Amplification TechniquesMolecular Diagnostic Techniques

Citations

2,677

FWCI

9.85

field-weighted impact

References

Percentile

98%

vs. same field & year

Citations per year

Cited by

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer